# Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases

> **NCT05129202** · — · COMPLETED · sponsor: **Hunan Province Tumor Hospital** · enrollment: 200 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** immune therapy

## Key facts

- **NCT ID:** NCT05129202
- **Lead sponsor:** Hunan Province Tumor Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-03
- **Primary completion:** 2021-09-05
- **Final completion:** 2022-10-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05129202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05129202, "Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05129202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*